Drugs Controller General of India - Organiser

Drugs Controller General of India

COVAXIN

Bharat Biotech seeks DCGI’s permission to conduct Covaxin booster trials in the 2-18 age group

Representative Image

India’s expanding COVID-19 vaccination programme set to achieve new milestones

Representative Image

Corbevax COVID-19 vaccine gets DCGI’s nod for children aged 5-12

Representative Image

DCGI grants EUA to ZycovD COVID vaccine for a two-dose regimen for children above 12

Representative Image

DCGI gives emergency use authorisation to Covaxin for the 6-12 age group